O-Antigen Targeted Vaccines Against Escherichia coli May Be Useful in Reducing Morbidity, Mortality, and Antimicrobial Resistance Post date 29 January 2022 Royer G, Clermont O, Condamine B, Mercier-Darty M, Laouénan C, Lefort A, Denamur E, de Lastours V; COLIBAFI and SEPTICOLI Groups. No abstract available. Read publication ← Nurses and physicians at high risk of burnout in French level III neonatal intensive care units: an observational cross-sectional study. → Conservative management or cesarean hysterectomy for placenta percreta? A subgroup analysis of the PACCRETA study is needed
FHU PREMA